At baseline, TRD patients exhibited enhanced pro-apoptotic mRNA expression, specifically showing increased levels of Bax, p53, and cytochrome c, whereas the mRNA of the anti-apoptotic Bcl-2 was decreased compared to healthy controls. The gene discussed is BAX; the disease is treatment resistant depression.